Literature DB >> 170224

Cell-mediated cytotoxicity to chemically-induced rat tumours.

M Zöller, M R Price, R W Baldwin.   

Abstract

Cell-mediated immune reactions against carcinogen-induced rat tumours were demonstrated by the in vitro microcytotoxicity test. Lymph-node cells from syngeneic rats immunized against individual aminoazo-dye-induced hepatomas or 3-methylcholanthrene-induced sarcomas were cytotoxic for cells of the immunizing tumour compared with the effects of normal lymph-node cells. Only a low level of cross-reactivity was detectable against target cells derived from otherr tumours. Conversely, lymph-node cells from tumour -bearing rats were cross-reactive against a range of tumour cells, suggesting that the tumour-bearer was sensitized against a common antigen(s) as well as the individually specific antigen associated with these tumours. Lymph-node cells were reactive at an early time (from day 2) after tumour implantation and their cytotoxic potential persisted until terminal stages of tumour growth. Spleen cells from tumour-bearer and tumour-immune donors also exhibited comparable cytotoxic reactivities of the same specificity as that shown by lymph-node cell preparations. These findings are discussed in relation to the development of cell-mediated immune responses in the tumour-bearing rat and in immunized rats which are capable of rejecting transplanted tumour cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170224     DOI: 10.1002/ijc.2910160409

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Immunomorphologic lymph node changes in rats bearing experimental breast tumors.

Authors:  D R Ciocca
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

2.  Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.

Authors:  M Zöller; M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.